A detailed history of Maplelane Capital, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Maplelane Capital, LLC holds 842,000 shares of TEVA stock, worth $21.4 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
842,000
Holding current value
$21.4 Million
% of portfolio
0.45%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$15.38 - $20.2 $12.9 Million - $17 Million
842,000 New
842,000 $17 Million
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $6 - $9
-1 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $8 - $15
1 New
1 $0

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $28.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Maplelane Capital, LLC Portfolio

Follow Maplelane Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maplelane Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Maplelane Capital, LLC with notifications on news.